Dhruv Khullar

Dhruv Khullar, physician and New Yorker medical correspondent, explores GLP-1 drugs like Ozempic and their surprising cultural and clinical ripple effects. He traces their history, shares widespread anecdotes tying them to reduced cravings, and probes how they act on the brain’s reward system. He also weighs possible downsides, ethical questions, and the need for rigorous trials.

Dhruv Khullar, physician and New Yorker writer on health, and Alex Ward, national security reporter for The Wall Street Journal, join to tackle high-stakes topics. They discuss military risks if strikes on Iran expand. They also explore rising GLP-1 drugs like Ozempic and early research on addiction. Short takes on winter storms and regional violence round out the conversation.

Dhruv Khullar, a contributing writer at The New Yorker and a practicing physician, dives into the chaotic landscape of vaccine policy in the U.S. under Donald Trump's second term. The discussion focuses on the politicization of vaccines, the role of newly appointed skeptics in federal health agencies, and how states are stepping up to fill the void left by the federal government. Khullar highlights the complexities of vaccine access, the impact of shifting guidelines on public trust, and the surprising pro-vaccine stance of some red states like West Virginia.